Grantham, Mayo, Van Otterloo & Co (GMO)
ALB icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Albemarle ALB Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ALB Stock Details ALB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121M Sell
897,013
-9,670
-1% -$1.71M 0.27% 45
2026
Q1 		$163M Sell
906,683
-16,388
-2% -$2.8M 0.42% 38
2025
Q4 		$131M Buy
923,071
+191,582
+26% +$21.7M 0.33% 39
2025
Q3 		$59.3M Sell
731,489
-104,317
-12% -$8.05M 0.17% 58
2025
Q2 		$52.4M Buy
835,806
+47,200
+6% +$2.79M 0.16% 66
2025
Q1 		$56.8M Buy
788,606
+175,608
+29% +$14.3M 0.18% 56
2024
Q4 		$52.8M Buy
612,998
+97,000
+19% +$9.66M 0.17% 59
2024
Q3 		$48.9M Buy
515,998
+433,798
+528% +$38.5M 0.15% 91
2024
Q2 		$7.85M Buy
82,200
+5,800
+8% +$690K 0.03% 284
2024
Q1 		$10.1M Buy
+76,400
New +$9.41M 0.04% 262
2023
Q1 		– Sell
-6,262
Closed -$1.36M – 697
2022
Q4 		$1.36M Buy
6,262
+3,000
+92% +$800K 0.01% 479
2022
Q3 		$863K Buy
+3,262
New +$829K 0.01% 517
2021
Q2 		– Sell
-128,195
Closed -$18.7M – 707
2021
Q1 		$18.7M Buy
128,195
+83,273
+185% +$13.4M 0.1% 158
2020
Q4 		$6.63M Sell
44,922
-12,109
-21% -$1.44M 0.04% 253
2020
Q3 		$5.09M Sell
57,031
-74,070
-56% -$6.56M 0.04% 236
2020
Q2 		$10.1M Sell
131,101
-137,809
-51% -$9.36M 0.08% 152
2020
Q1 		$15.2M Sell
268,910
-167,790
-38% -$12.9M 0.13% 106
2019
Q4 		$31.9M Buy
436,700
+43,600
+11% +$2.91M 0.21% 77
2019
Q3 		$27.3M Sell
393,100
-56,500
-13% -$3.85M 0.19% 82
2019
Q2 		$31.7M Buy
449,600
+249,000
+124% +$18.4M 0.22% 72
2019
Q1 		$16.4M Buy
200,600
+6,200
+3% +$507K 0.12% 130
2018
Q4 		$15M Buy
194,400
+31,300
+19% +$2.95M 0.12% 115
2018
Q3 		$16.3M Buy
163,100
+28,700
+21% +$2.78M 0.11% 119
2018
Q2 		$12.7M Buy
134,400
+58,000
+76% +$5.57M 0.09% 139
2018
Q1 		$7.08M Buy
+76,400
New +$8.42M 0.04% 188
2016
Q3 		– Sell
-3,506
Closed -$278K – 511
2016
Q2 		$278K Hold
3,506
– – ﹤0.01% 522
2016
Q1 		$224K Buy
+3,506
New +$192K ﹤0.01% 540

Other funds holding ALB

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ALB Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Albemarle (ALB) stake by 1.1% in Q2 2026, selling an estimated $1.71M and leaving 897,013 shares worth $121M. The position accounts for 0.27% of the portfolio, ranked #45.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ALB in Q1 2016 and has held it in 27 quarters since. The position peaked at $163M in Q1 2026. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 897,013 shares of Albemarle worth $121M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 9,670 Albemarle shares in Q2 2026, an estimated $1.71M.
  • Albemarle made up 0.27% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #45 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Albemarle in Q1 2016 and has held it in 27 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Albemarle position peaked at $163M in Q1 2026.
  • 942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.